We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . . X close

Single Use Bioprocessing Market Size, Growth, Share & Trends Analysis

Report Code BT 4630
Published in Oct, 2025, By MarketsandMarkets™

Choose License Type

Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030

icon1
USD 33.67 BN
MARKET SIZE 2030
icon2
CAGR 13.3%
(2025-2030)
icon3
570
REPORT PAGES
icon4
740
MARKET TABLES

OVERVIEW

Single Use Bioprocessing Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The single-use bioprocessing market is expected to grow from an estimated USD 18.01 billion in 2025 to USD 33.67 billion by 2030, at a CAGR of 13.3% during the forecast period. Several factors contribute to the growth of the single-use bioprocessing market, including the growing adoption among CDMOs & CMOs, increased productivity, reduced risk of cross-contamination, and the requirement for low capital investment.

KEY TAKEAWAYS

  • BY PRODUCT
    Based on product, the single-use bioprocessing market is divided into two segments: consumables and equipment. Among these, the consumables segment held the largest market share in 2024. This significant portion can be attributed to continuous demand for disposable components, such as filters, bags, and tubing, driven by their critical role in ensuring efficiency, cost-effectiveness, and sterility throughout the bioprocessing workflow.
  • BY APPLICATION
    Based on application, the market is segmented into cell culture, filtration, purification, mixing, storage & transfer, and other applications. In 2024, the filtration segment accounted for the largest share of the single-use bioprocessing market, owing to the wide use of equipment for various filtration applications in the pharmaceuticals industry and increased filtration requirements in the biopharmaceutical industry.
  • BY WORKFLOW
    Based on workflow, the single-use bioprocessing market is segmented into upstream and downstream bioprocessing. The upstream bioprocessing segment dominated the single-use bioprocessing market. The large share of this segment can be attributed to the wide use of single-use bioprocessing in biopharmaceutical formulation.
  • BY MOLECULE TYPE
    Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies. In 2024, the monoclonal antibodies segment accounted for the largest share of the single-use bioprocessing market. This is attributed to the increasing pharmaceutical R&D drug pipeline, the increasing incidence of cancer, and the rising usage & demand for cancer therapy.
  • BY END USER
    In 2024, the pharmaceutical & biotechnology companies segment held the largest share of the single-use bioprocessing market due to the higher adoption of single-use bioprocessing equipment and consumables by pharmaceutical companies, the stringent regulatory scenario, the rising R&D activities, increased production of biologics, and the growing manufacturing of biologics and biosimilars in developed countries.
  • BY REGION
    The Asia Pacific region is projected to experience the fastest growth rate during the forecast period due to the increasing demand for biosimilars, investments by biopharmaceutical companies & CMOs in emerging Asia Pacific countries, and the focus on developing advanced healthcare products.
  • COMPETITIVE LANDSCAPE
    The competitive landscape involves analyzing key growth strategies implemented by major players in the single-use bioprocessing market. Companies in the global market have adopted various approaches to expand their presence and increase market shares. The primary strategies utilized by these leading market players include product launches, agreements, expansions, and acquisitions.

The single-use bioprocessing market is witnessing significant expansion due to the increasing adoption of disposable technologies in the biopharmaceutical sector. These technologies are increasingly favored for their ability to streamline production processes and reduce downtime associated with cleaning and sterilizing traditional systems. Furthermore, advancements in single-use technologies, such as bioreactors, filtration systems, and chromatography, have enhanced the efficiency and scalability of bioprocessing operations.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The increasing adoption of single-use bioprocessing among CMOs, CROs, startups, and small enterprises, reduced operational complexity, growing biologics market, and technological advancements in single-use bioreactors create new revenue pockets for single-use bioprocessors (SUB) providers. Many SUB providers are currently missing out on opportunities in the growing biologics and cell & gene therapies market. The increasing penetration of SUB technologies for drug discovery, majorly among contract manufacturing service providers, and the advent of automation in single-use bioprocessing are expected to change the business revenue mix for single-use bioprocessing.

Single Use Bioprocessing Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing adoption among CDMOs and CMOs
  • Increased productivity and reduced risk of cross-contamination
RESTRAINTS
Impact
Level
  • Issues related to leachables and extractables
  • Impact of PFAS restrictions on product development
OPPORTUNITIES
Impact
Level
  • Untapped market potential in emerging economies
  • Customization options driving growth and innovation
CHALLENGES
Impact
Level
  • Lack of standardization of single-use designs
  • Waste disposal

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increased productivity and reduced risk of cross contamination

Single-use systems offer a streamlined approach, eliminating the need for extensive cleaning procedures by employing disposable components. This feature enables manufacturers to accelerate product substitutions and process transitions, maximizing equipment utilization and overall production throughput. By minimizing downtime and enhancing operational efficiency, single-use bioprocessing technologies allow manufacturers to meet the increasing demand for biologics and accelerate time-to-market for new therapies, ultimately driving revenue growth and market expansion. Moreover, single-use systems offer a closed and disposable design, minimizing the risk of microbial contamination and cross-contamination between batches. This inherent sterility significantly enhances product purity and consistency, meeting stringent regulatory requirements and supporting consumer confidence in the safety and efficacy of biologic drugs.

Restraint: Issues related to leachable and extractables

Leachables are chemical compounds that migrate from the single-use materials (plastic bags, tubing, and filters) into the biopharmaceutical product, while extractable are substances that can be extracted from the single-use materials under extreme conditions, such as high temperatures or different solvents. The presence of leachables and extractables in biopharmaceutical products can pose risks to product quality, safety, and regulatory compliance, thereby presenting a significant obstacle to the widespread adoption of single-use bioprocessing technologies.

Opportunity: Untapped market potential in emerging economies

The global bioprocessing market has witnessed substantial growth, owing to the adoption of single-use technologies (SUTs). These technologies offer significant advantages over traditional stainless-steel systems, including reduced risk of contamination, lower capital costs, and increased operational flexibility. While developed markets in North America and Europe have seen widespread adoption of SUTs, there remains considerable untapped market potential in emerging economies. These regions present a unique opportunity for expansion due to several factors, including the growing healthcare needs, the increasing investment in biopharmaceutical infrastructure, and favorable government policies. Emerging countries, such as China, India, Brazil, and Mexico, are expected to offer significant growth opportunities for players operating in the single-use bioprocessing market.

Challenge: Lack of standardization of single-use designs

The lack of standardization affects various aspects of bioprocessing, from manufacturing and integration to regulatory compliance and supply chain management, posing substantial hurdles for widespread adoption and efficient implementation. There is variability in design and components across different manufacturers. Unlike traditional stainless-steel systems, which have well-established industry standards, single-use systems are often custom-designed, leading to inconsistencies. The absence of standardized connectors, tubing, and other components means that systems from different suppliers are often not compatible with one another. This lack of interchangeability complicates system integration and increases the risk of operational inefficiencies.

single use bioprocessing market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Implemented a 100% closed single-use cell-culture facility, scalable 50–2,000 L single-use equipment, designed and started up within ~18 months; included process simulation, full USP/DSP design, and automation (DCU/MFCS) Faster startup (18 months from ground-breaking)| 62% lower equipment investment vs stainless | Water/steam savings per batch (≈141,000 L WFI; 205,500 L purified water; 148 kg steam) | Multi-product flexibility meeting US/EU/China cGMP standards
Transferred an antibody production process onto Cytiva Xcellerex (XDR) single-use bioreactors across development and production scales; executed risk assessments (film, agitation, gassing), ran 200 L engineering runs with in-process monitoring (e.g., CO2), and benchmarked against commercial-scale (2,000 L) operations Achieved process comparability on viable cell density, viability, integral viable cell count, and titer| Established a second qualified SUB platform to enhance capacity and supply resilience | Demonstrated ability to operate multiple 2,000 L XDRs in parallel (aggregate working volume to ~12,000 L) without compromising product quality
Partnered with Sartorius to deliver a flexible mammalian SUB facility for mAbs/recombinant proteins/ADCs in ~18 months, centered on Biostat STR and related single-use technologies High reliability and scalability of SUB platform | Reported 100% cell-culture success rate with 0% contamination post-startup | Flexible, multi-product cGMP capacity aligned to US/EU/China requirements and “just-in-time” batch scheduling

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The single-use bioprocessing market operates within a complex ecosystem that includes a wide array of stakeholders, each playing a crucial role in the development, adoption, and implementation of single-use technologies. This ecosystem encompasses raw material suppliers, product providers (single-use equipment and consumables), end users (pharmaceutical & biopharmaceutical companies), and regulatory authorities.

Single Use Bioprocessing Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Single Use Bioprocessing Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Single-use Bioprocessing Market, By Product

In 2024, the consumables segment accounted for the largest share of the single-use bioprocessing market. The segmental growth can be attributed to their ability to create a recurring revenue stream, bags, assemblies, filters, connectors, and sensors that are purchased every batch. Their high volumes and frequent replacement outpace one-time equipment buys, and they span USP and DSP with product/film validation that reinforces ongoing pull-through from the installed base.

Single-use Bioprocessing Market, By Molecule Type

In 2024, the monoclonal antibodies segment accounted for the largest share of the single-use bioprocessing market. Monoclonal antibodies (mAbs) dominate as they account for the largest number of late-stage and commercial biologics. The growing biosimilar pipeline, driving steady, high run-rates, further drives the segment. Their well-standardized fed-batch processes align with single-use bioreactor scales, titers, and closed-process requirements, enabling predictable scale-up and multi-product scheduling.

Single-use Bioprocessing Market, By Application

In 2024, the filtration segment accounted for the largest market share. Filtration is a large, durable single-use application because it spans USP and DSP and is consumables-intensive with batch-by-batch replacement. Regulatory expectations for closed, sterile operations and growth in vector/LNP workflows sustain high volume usage and recurring spend.

Single-use Bioprocessing Market, By End User

In 2024, the pharmaceutical & biotechnology segment accounted for the largest market share. Single-use equipment decreases cross-product/batch contamination risks, increases product integrity, reduces downtime, lowers cleaning costs, decreases facility setup expenses, provides a smaller manufacturing footprint, and improves facility flexibility and adaptability. These advantages drive the adoption of single-use assemblies by pharmaceutical & biopharmaceutical companies.

REGION

Asia Pacific to be fastest-growing region in global single-use bioprocessing market during forecast period

The high growth rate in the Asia Pacific market can be attributed to increasing demand for biosimilars, investments by biopharmaceutical companies & CMOs in emerging Asia Pacific countries, and the focus on developing advanced healthcare products. With the increasing investment in healthcare infrastructure and supportive government policies, the region is poised for substantial growth in this field. As perfusion technology is adopted in biomanufacturing processes, the demand for single-use bioprocessing is expected to increase with the growing production of biosimilars.

Single Use Bioprocessing Market Region

single use bioprocessing market: COMPANY EVALUATION MATRIX

Sartorius is recognized as a Star player in the single-use bioprocessing market, supported by its Biostat STR and Ambr platforms that provide a consistent development-to-GMP scale path. The company’s portfolio spans bioreactors, filtration and fluid-management components, single-use sensors, and custom assemblies, supported by global service and validation capabilities. Avantor is positioned as an Emerging Leader, driven by engineered single-use assemblies and flow-path kits used across upstream and downstream operations. A growing global cleanroom network, standardization toolsets, and inventory solutions strengthen its role with innovators and CDMOs.

Single Use Bioprocessing Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 16.51 Billion
Market Forecast in 2030 (Value) USD 33.67 Billion
Growth Rate CAGR of 13.3% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD BN)
Report Coverage Revenue forecast, company revenue analysis, competitive landscape, growth factors, and trends
Segments Covered
  • By Product: Equipment and Consumables
  • By Application:
    • Cell Culture
    • Filtration
    • Purification
    • Mixing
    • Storage & Transfer
    • and Other Applications
  • By Workflow: Upstream and Downstream Bioprocessing
  • By Molecule Type:
    • Monoclonal Antibodies (mAbs)
    • Vaccines
    • Therapeutic Proteins & Peptides
    • and Cell & Gene Therapies
  • By End User:
    • Pharmaceutical & Biotechnology Companies
    • CROs & CMOs
    • and Other End Users
Regional Scope North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

WHAT IS IN IT FOR YOU: single use bioprocessing market REPORT CONTENT GUIDE

Single Use Bioprocessing Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Single-use Bioprocessing Mixers Market Market size & forecast at the regional and country level with segmentation by scale type ( 0-50L, 50L-100L, 100L-500 L, 500L - 2000L, 2000L – 3000L, >3000L). The regions covered in the market study include North America, Europe, Asia Pacific, and the Rest of the World
  • Provides granular insights for scale-specific demand trends
  • Supports go-to-market and pricing strategies
  • Identifies high-growth countries and applications
  • Aids in competitive benchmarking and investment planning
2D Bioprocess Freeze Containers Market Market size and forecast analysis for 2D bioprocess freeze containers (bags) across regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, segmented by application (drug substance and drug product). Additionally, estimated the global percentage share of freeze containers (bags) versus freeze bottles.
  • Enables product positioning vs. bottles and regional substitution analysis
  • Informs manufacturing capacity planning and bag-spec supply chain
  • Supports market-share estimates, pricing strategy and application-specific demand forecasting
Pharmaceutical Filtration Market Market size and forecast for the pharmaceutical filtration market, segmented by consumables (filters and other consumables) and systems. The market size & forecast were also calculated for each product by application, technique, modality, scale of operation, and region. Analysis was delivered at the global, regional, and country level. Enables evaluation of growth opportunities across consumables and system categories, supports product portfolio prioritization, and informs strategic decisions on regional expansion, competitive benchmarking, and investment allocation.

RECENT DEVELOPMENTS

  • September 2025 : Thermo Fisher Scientific Inc. acquired the Purification & Filtration business of Solventum for ~USD 4.0 billion. The acquisition strengthens Thermo Fisher’s bioproduction offerings with advanced filtration technologies that improve quality and efficiency across upstream and downstream workflows.
  • March 2025 : ABEC launched its single-use Advanced Therapy Bioreactor (ATB), which is designed to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs).
  • June 2025 : Sartorius announced the completion of a bioprocess manufacturing and R&D capacity expansion in Aubagne, France. Through this expansion, the company aims to strengthen supply of fluid management technologies, such as single-use bags, used for cell culture, storage and shipping of fluids in biopharmaceutical manufacturing.
  • November 2024 : Sartorius AG opened its new Center for Bioprocess Innovation in Massachusetts, US. The 63,000 sq. ft. facility supports process development, optimization, and validation for advanced therapeutics, including cell and gene therapies.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
21
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
67
PREMIUM INSIGHTS
98
MARKET OVERVIEW
114
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    OPPORTUNITIES
    CHALLENGES
INDUSTRY TRENDS
143
  • 6.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.2 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITION RIVALRY
  • 6.3 MACROECONOMICS INDICATORS
    GLOBAL R&D EXPENDITURE IN BIOPHARMACEUTICALS
    TRENDS IN GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY
    TRENDS IN CONTRACT MANUFACTURING & OUTSOURCING (CROS/CMOS)
  • 6.4 VALUE CHAIN ANALYSIS
  • 6.5 ECOSYSTEM ANALYSIS
  • 6.6 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022-2024
    AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
  • 6.7 TRADE ANALYSIS (2020–2024)
    IMPORT SCENARIO
    EXPORT SCENARIO
  • 6.8 KEY CONFERENCES AND EVENTS, 2026–2026
  • 6.9 INVESTMENT AND FUNDING SCENARIO
  • 6.10 TECHNOLOGY ANALYSIS
    KEY EMERGING TECHNOLOGIES
    - Filtration
    - Chromatography
    - Fermentation
    COMPLEMENTARY TECHNOLOGIES
    - Automation & Control Systems
    - 3D Cell Culture
    - Continuous Bioprocessing
    ADJACENT TECHNOLOGIES
    - Bioprocess Modeling & Simulation
    - Bioprocess Monitoring & Data Analytics
  • 6.11 TECHNOLOGY/PRODUCT ROADMAP
  • 6.12 PATENT ANALYSIS
  • 6.13 FUTURE APPLICATIONS
    SINGLE-USE SYSTEMS IN CELL & GENE THERAPY MANUFACTURING
    INTEGRATION WITH CONTINUOUS BIOPROCESSING
    ADVANCED SINGLE-USE BIOREACTORS FOR PERSONALIZED MEDICINE
  • 6.14 IMPACT OF AI/GEN AI ON SINGLE-USE BIOPROCESSING MARKET
    TOP USE CASES AND MARKET POTENTIAL
    BEST PRACTICES IN SINGLE USE BIOPROCESSING
    CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOPROCESSING MARKET
    INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON PLAYERS
  • 6.15 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
    SARTORIUS: COMMERCIAL BIOMANUFACTURING WITH SINGLE-USE TECHNOLOGIES
    THERMO FISHER SCIENTIFIC: REVOLUTIONIZING VACCINES WITH THERMO SCIENTIFIC HYPERFORMA SINGLE-USE FERMENTOR
  • 6.16 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
    DECISION-MAKING PROCESS
    BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    ADOPTION BARRIERS & INTERNAL CHALLENGES
    UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 6.17 SUSTAINABILITY AND REGULATORY LANDSCAPE
    REGIONAL REGULATIONS AND COMPLIANCE
    - Industry Standards
    - Regulatory framework
    - Regulatory Bodies, Government Agencies, And Other Organizations
    SUSTAINABILITY INITIATIVES
    CERTIFICATIONS, LABELING, ECO-STANDARDS
  • 6.18 IMPACT OF 2026 US TARIFF – SINGLE-USE BIOPROCESSING MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - US
    - Europe
    - APAC
    IMPACT ON END-USE INDUSTRIES
    - Pharmaceutical & Biotechnology Companies
    - CROS & CMOS
SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
188
  • 7.1 INTRODUCTION
  • 7.2 EQUIPMENT
    SINGLE-USE BIOREACTORS
    - ≤ 10 L Bioreactors
    - 11-100 L Bioreactors
    - 101-500 L Bioreactors
    - 501-1500 L Bioreactors
    - >1,500 L Bioreactors
    - Single Use Bioreactors Market, By Molecule Type
    SINGLE-USE FILTRATION SYSTEMS
    - Manufacturing-scale Filtration Systems
    - Pilot-scale Filtration Systems
    - R&D-scale Filtration Systems
    SINGLE-USE MIXING SYSTEMS
    - Manufacturing-scale Mixing Systems
    - Pilot-scale Mixing Systems
    - R&D-scale Mixing Systems
    SINGLE-USE CHROMATOGRAPHY SYSTEMS
    OTHER SINGLE-USE EQUIPMENT
  • 7.3 CONSUMABLES
    SINGLE-USE BAGS & CONTAINERS
    - 2D Bags & Containers
    - 3D Bags & Containers
    SINGLE-USE FILTERS
    SINGLE-USE ASSEMBLIES
    - Bag Assemblies
    - Bottle Assemblies
    - Filtration Assemblies
    - Mixing System Assemblies
    - Other Assemblies
    SINGLE-USE CHROMATOGRAPHY COLUMNS
    SINGLE-USE SENSORS
    - Single-use Sensors Market, By Product
    - Global Single Use Sensors Market, By Molecule Type
    - Global Single Use Sensors Market, By Application
    - Global Single Use Sensors Market, By Workflow
    OTHER SINGLE-USE CONSUMABLES
    - Tubing
    - Connectors
    - Disconnectors
    - Adaptors
    - Valves
    - Other Consumables
SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
234
  • 8.1 INTRODUCTION
  • 8.2 FILTRATION
  • 8.3 CELL CULTURE
  • 8.4 MIXING
  • 8.5 PURIFICATION
  • 8.6 STORAGE & TRANSFER
  • 8.7 OTHER APPLICATIONS
SINGLE-USE BIOPROCESSING MARKET, BY WORKFLOW (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
277
  • 9.1 INTRODUCTION
  • 9.2 UPSREAM BIOPROCESSING
  • 9.3 DOWNSTREAM BIOPROCESSING
    SINGLE-USE BIOPROCESSING MARKET, BY MOLECULE TYPE (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
SINGLE-USE BIOPROCESSING MARKET, BY MOLECULE TYPE (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
301
  • 10.1 INTRODUCTION
  • 10.2 MONOCLONAL ANTIBODIES
    SINGLE-USE BIOPROCESSING MARKET FOR MONOCLONAL ANTIBODIES, BY PRODUCT
  • 10.3 VACCINES
    SINGLE-USE BIOPROCESSING MARKET FOR VACCINES, BY PRODUCT
  • 10.4 THERAPEUTIC PROTEINS & PEPTIDES
    SINGLE-USE BIOPROCESSING MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY PRODUCT
  • 10.5 CELL & GENE THERAPIES
    SINGLE-USE BIOPROCESSING MARKET FOR CELL & GENE THERAPIES, BY PRODUCT
SINGLE-USE BIOPROCESSING MARKET, BY END USER (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
365
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 11.3 CROS & CMOS
  • 11.4 OTHER END USERS
SINGLE-USE BIOPROCESSING MARKET, BY REGION (MARKET SIZE (2023-2030) & FORECAST TO 2030, VALUE USD MILLION)
398
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    UK
    FRANCE
    ITALY
    SPAIN
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    JAPAN
    INDIA
    SOUTH KOREA
    AUSTRALIA
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    GCC COUNTRIES
    - Saudi Arabia
    - UAE
    - Rest of GCC countries
    REST OF MIDDLE EAST
  • 12.7 AFRICA
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
450
  • 13.1 OVERVIEW
  • 13.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN
    COMPETITIVE STRATEGIES INITIATIVES
    OPERATIONAL STRATEGIES INITIATIVES (WORKFORCE UPSKILLING, LEADERSHIP DEVELOPMENTS, GLOBAL COLLABORATIONS, ORGANIZATIONAL AGILITY, ETC.)
  • 13.3 REALTIME FINANCIAL ANALYSIS
    REVENUE ANALYSIS, 2020-2024
    PROFITABILITY/ MARGIN ANALYSIS, 2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
  • 13.5 BRAND/PRODUCT COMPARISON
  • 13.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Product footprint
    - Application footprint
    - Workflow footprint
  • 13.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 13.8 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
465
  • 14.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    SARTORIUS AG
    MERCK KGAA
    DANAHER CORPORATION
    GETINGE AB
    EPPENDORF SE
    ENTEGRIS
    3M COMPANY
    CORNING INCORPORATED
    LONZA
    AVANTOR, INC.
    REPLIGEN CORPORATION
    PARKER HANNIFIN CORPORATION
    ALFA LAVAL CORPORATE AB
    SAINT-GOBAIN
    METTLER TOLEDO
    PORVAIR PLC
    EATON CORPORATION PLC
  • 14.2 OTHER PLAYERS
    ABEC, INC.
    NEWAGE INDUSTRIES
    BROADLEY-JAMES CORPORATION
    PBS BIOTECH, INC
    SENTINEL PROCESS SYSTEMS, INC.
    MEISSNER FILTRATION PRODUCTS INC.
    SATAKE CHEMICAL EQUIPMENT MFG., LTD
    HAMILTON COMPANY
    MEMBRANE SOLUTIONS
    COLE-PARMER INSTRUMENT COMPANY, LLC
    DISTEK, INC
    ESCO LIFESCIENCES
    TECNIC BIOPROCESS EQUIPMENT MANUFACTURING
APPENDIX
487
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS 

Methodology

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioprocessing market. The secondary sources used for this study include the World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), the National Institute for Bioprocessing Research and Training (NIBRT), the Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), the European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), the National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioprocessing and Biotechni ques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

After acquiring foundational knowledge about the global single-use bioprocessing market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

The following is a breakdown of the primary respondents:

Single-use Bioprocessing Market

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size from the estimation process, the total market was split into several segments and subsegments.

Single-use Bioprocessing Market

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-use bioprocessing refers to the use of disposable, pre-sterilized equipment and consumables in the production of biopharmaceutical products. Single-use technologies (SUTs) include a range of products, such as bioreactors, mixers, filters, tubing, connectors, and storage bags, all designed for one-time use. Key benefits of single-use bioprocessing include reduced risk of cross-contamination, low capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive to produce biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

Stakeholders

  • Single-use bioprocessing equipment and consumables manufacturing companies
  • Single-use bioprocessing equipment and consumables distributors
  • Pharmaceutical and biotechnology companies
  • Contract manufacturing companies (CMOs)
  • Contract research organizations (CROs)
  • Academic and research institutes
  • Life science companies
  • Market research and consulting firms
  • Venture capitalists and investors
  • Government organizations
  • Private research firms

Report Objectives

  • To define, describe, and forecast the single-use bioprocessing market, by product, application, workflow, molecule type, and end user, in terms of value
  • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
  • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players in the single-use bioprocessing market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the single-use bioprocessing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the single-use bioprocessing market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

 

Adjacent Markets

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Single-use Bioprocessing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Growth opportunities and latent adjacency in Single-use Bioprocessing Market

Richard

Mar, 2022

Which is the fastest growing market of Single use Bioprocessing Market?.

Joseph

Mar, 2022

Cen you enlighten us with your market intelligence to grow and sustain in Single use Bioprocessing Market?.

Thomas

Mar, 2022

What are the growth estimates for Single use Bioprocessing Market till 2026?.